A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes
Date first appeared online 15/01/2019
DOI 10.1177/1932296818821706
Authors Bain S.
Journal Name Journal of Diabetes Science and Technology
Volume

Documents